Not independent
Tenure on this board
0.8 yrs
4 nominees · 1 ballot item.
A single management proposal to amend the Certificate of Incorporation to increase total authorized shares (common stock from 150,000,000 to 300,000,000 and total capital stock from 180,000,000 to 330,000,000).
Approve an amendment to the Company’s Certificate of Incorporation to increase authorized shares of capital stock from 180,000,000 to 330,000,000, including increasing authorized common stock from 150,000,000 to 300,000,000, to provide flexibility for issuance for financings, equity awards, conversions and other corporate purposes.
This management proposal asks stockholders to approve an amendment to the Company’s Certificate of Incorporation to increase authorized capital stock from 180 million to 330 million shares, including increasing authorized common stock from 150 million to 300 million. Management and the Board are seeking shareholder approval to ensure the Company has sufficient authorized but unissued shares to meet existing commitments (including issued warrants, convertible note settlements and reserved equity incentive plan shares) and to enable future financings, strategic transactions, equity awards and other corporate needs without the delay or expense of calling additional stockholder votes. The amendment would allow the Board to issue additional shares at its discretion subject to law and applicable NYSE rules, which provides operational and financing flexibility, particularly given outstanding warrants and convertible instruments described in the proxy. The Board highlights that additional authorized shares will help the Company satisfy obligations and pursue capital-raising activities necessary for its business plan. The proxy also acknowledges potential downsides: issuance of additional shares may dilute existing ownership, depress per-share metrics and could, under certain circumstances, be used in a manner that has an anti-takeover effect, though the Board states that is not its intent. The Board reserves the right to abandon the amendment even if approved by stockholders, giving it discretion over whether to effect the change prior to filing. The Board’s unanimous recommendation to vote FOR is based on perceived need for flexibility to implement financings and other transactions promptly and to avoid the cost/time of additional meetings; shareholders should weigh that operational flexibility against possible dilution and the theoretical anti-takeover consequences. On balance, the proposal is a standard corporate housekeeping authorization to increase capacity for equity issuance, but its governance implications (dilution, potential to affect takeovers) merit consideration by investors evaluating capital structure and managerial incentives.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Aristides Capital LLC | 0.1% | 67,312 | $118K |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 0.1% | 53,306 | $93K |
| 3 | UBS Group AG | 0.0% | 30,854 | $54K |
| 4 | FMR LLC | 0.0% | 29,112 | $51K |
| 5 | Abel Hall, LLC | 0.0% | 28,856 | $50K |
| 6 | Wealth Management Partners, LLC | 0.0% | 28,116 | $49K |
| 7 | VANGUARD GROUP INC | 0.0% | 24,439 | $43K |
| 8 | MILLENNIUM MANAGEMENT LLC | 0.0% | 18,972 | $33K |
| 9 | XTX Topco Ltd | 0.0% | 18,024 | $32K |
| 10 | NORTHERN TRUST CORP | 0.0% | 16,974 | $30K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.